Package 63323-325-24

{"route": ["INTRAVENOUS"], "spl_id": "5913c199-275d-40b3-a249-050106e058de", "openfda": {"upc": ["0363323325435", "0363323325411"], "unii": ["927L42J563"], "rxcui": ["1734932", "1734934"], "spl_set_id": ["badf347b-eeee-4239-9c74-966f262925aa"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-14)  / 10 mL in 1 VIAL, SINGLE-DOSE (63323-325-41)", "package_ndc": "63323-325-14", "marketing_start_date": "20001017"}, {"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-24)  / 20 mL in 1 VIAL, SINGLE-DOSE (63323-325-43)", "package_ndc": "63323-325-24", "marketing_start_date": "20001017"}], "brand_name": "Acyclovir", "product_id": "63323-325_5913c199-275d-40b3-a249-050106e058de", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "63323-325", "generic_name": "acyclovir", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA074930", "marketing_category": "ANDA", "marketing_start_date": "20001017", "listing_expiration_date": "20261231"}